Current Report Filing (8-k)
February 09 2022 - 5:00AM
Edgar (US Regulatory)
0001541165
false
0001541165
2021-06-07
2021-06-07
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported):
June 7, 2021
ONE 4 ART LIMITED
(Exact Name of Registrant as Specified in its
Charter)
Nevada
|
|
333-179765
|
|
39-2078722
|
(State of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
1185 Avenue of the
Americas, 3rd Floor
New York, New York
|
|
10036
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(646) 768-8417
(Registrant’s telephone number, including
area code)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
|
Emerging growth company ☐
|
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b)
of the Act: None
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
N/A
|
|
N/A
|
|
N/A
|
Item 5.01 Changes in Control of Registrant.
On June 7, 2021, as a result of a
private transaction, 10,000,000 shares of Series A Preferred Stock, $0.001 par value per share (the “Shares”) of One 4 Art
Limited, a Nevada corporation (the “Company”), were transferred from Custodian Ventures, LLC to GREEN MEDIC PHARMS CORP. (the
“Purchaser”). As a result, the Purchaser became holders of approximately 98% of the voting rights of the issued and outstanding
share capital of the Company on a fully-diluted basis of the Company, and became the controlling shareholder. The consideration paid for
the Shares was $215,000. The source of the cash consideration for the Shares was personal funds of the Purchaser. In connection with the
transaction, David Lazar released the Company from all debts owed to him and/or Custodian Ventures, LLC.
Other than as described
below, there are no arrangements or understandings among both the former and new control persons and their associates with respect to
the election of directors of the Company or other matters. The information set forth in Item 5.02 of this Form 8-K is incorporated by
reference into this Item 5.01.
Item 9.01 Financial Statements and Exhibits.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
February 8, 2022
One 4 Art Limited
|
|
|
|
|
By:
|
/s/ David Lazar
|
|
|
David Lazar
|
|
Title:
|
President
|
|
One 4 Art (CE) (USOTC:ONFA)
Historical Stock Chart
From Jun 2024 to Jul 2024
One 4 Art (CE) (USOTC:ONFA)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about One 4 Art Limited (CE) (OTCMarkets): 0 recent articles
More One 4 Art Ltd News Articles